Tag: StockNews.com

StockNews.com Upgrades Nu Skin Enterprises (NYSE:NUS) to Buy

[ad_1]

Nu Skin Enterprises (NYSE:NUS – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Friday.

Several other research analysts have also recently weighed in on the stock. Citigroup dropped their price objective on shares of Nu Skin Enterprises from $14.00 to $11.50 and set a “neutral” rating for the company in a research report on Friday, August 9th. DA Davidson dropped their target price on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a research report on Monday, August 12th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $16.50.

Check Out Our Latest Analysis on Nu Skin Enterprises

Nu Skin Enterprises Trading Down 4.2 %

Shares of NUS opened at $8.00 on Friday. The company has a current ratio of 2.12, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. The stock has a 50 day simple moving average of $10.04 and a 200-day simple moving average of $11.79. Nu Skin Enterprises has a 1 year low of $8.00 and a 1 year high of $24.38. The stock has a market cap of $397.34 million, a PE ratio of -133.33 and a beta of 1.13.

Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04. The company had revenue of $439.10 million during the quarter, compared to analysts’ expectations of $431.87 million. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. Nu Skin Enterprises’s quarterly revenue was down 12.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.54 earnings per share. On average, sell-side analysts predict that Nu Skin Enterprises will post 0.78 EPS for the current fiscal year.

Institutional Investors Weigh In On Nu Skin Enterprises

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NUS. New York State Common Retirement Fund grew its holdings in Nu Skin Enterprises by 11.8% during the fourth quarter. New York State Common Retirement Fund now owns 41,000 shares of the company’s stock valued at $796,000 after purchasing an additional 4,334 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Nu Skin Enterprises by 17.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,157,697 shares of the company’s stock valued at $22,482,000 after buying an additional 173,193 shares during the period. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at $227,000. Janney Montgomery Scott LLC acquired a new stake in Nu Skin Enterprises during the 4th quarter worth $481,000. Finally, Kingsview Wealth Management LLC lifted its holdings in Nu Skin Enterprises by 39.0% during the fourth quarter. Kingsview Wealth Management LLC now owns 109,652 shares of the company’s stock worth $2,129,000 after acquiring an additional 30,792 shares in the last quarter. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

(Get Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

See Also

Receive News & Ratings for Nu Skin Enterprises Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

ABMN Staff

Source link

September 8, 2024
StockNews.com Begins Coverage on ANSYS (NASDAQ:ANSS)

[ad_1]

Investment analysts at StockNews.com assumed coverage on shares of ANSYS (NASDAQ:ANSS – Get Free Report) in a research report issued on Thursday. The brokerage set a “hold” rating on the software maker’s stock.

ANSS has been the topic of a number of other research reports. Rosenblatt Securities reduced their price target on ANSYS from $345.00 to $335.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. KeyCorp started coverage on ANSYS in a research report on Thursday, June 27th. They issued a “sector weight” rating on the stock. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $318.33.

Check Out Our Latest Research Report on ANSS

ANSYS Stock Performance

ANSS opened at $315.60 on Thursday. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.95 and a quick ratio of 2.80. The business has a fifty day simple moving average of $319.26 and a 200 day simple moving average of $327.30. ANSYS has a 1 year low of $258.01 and a 1 year high of $364.31. The company has a market capitalization of $27.55 billion, a PE ratio of 63.37, a price-to-earnings-growth ratio of 6.90 and a beta of 1.11.

ANSYS (NASDAQ:ANSS – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The software maker reported $2.50 EPS for the quarter, beating the consensus estimate of $1.92 by $0.58. ANSYS had a net margin of 21.30% and a return on equity of 11.51%. The business had revenue of $594.14 million for the quarter, compared to the consensus estimate of $550.30 million. During the same period in the prior year, the company posted $1.06 earnings per share. ANSYS’s revenue was up 19.6% compared to the same quarter last year. Research analysts expect that ANSYS will post 7.05 EPS for the current year.

Insider Transactions at ANSYS

In related news, Director Glenda Dorchak sold 159 shares of the firm’s stock in a transaction dated Monday, July 8th. The stock was sold at an average price of $330.81, for a total value of $52,598.79. Following the sale, the director now directly owns 3,782 shares of the company’s stock, valued at $1,251,123.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.46% of the stock is owned by insiders.

Hedge Funds Weigh In On ANSYS

Several institutional investors and hedge funds have recently added to or reduced their stakes in ANSS. Vanguard Group Inc. boosted its holdings in shares of ANSYS by 0.7% during the 1st quarter. Vanguard Group Inc. now owns 10,234,642 shares of the software maker’s stock valued at $3,553,058,000 after acquiring an additional 73,585 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of ANSYS by 1.9% during the fourth quarter. Franklin Resources Inc. now owns 1,508,715 shares of the software maker’s stock valued at $547,483,000 after purchasing an additional 27,893 shares in the last quarter. Norges Bank bought a new stake in shares of ANSYS during the fourth quarter worth about $282,329,000. Earnest Partners LLC increased its stake in shares of ANSYS by 2.5% in the second quarter. Earnest Partners LLC now owns 607,029 shares of the software maker’s stock valued at $195,160,000 after buying an additional 15,012 shares during the period. Finally, DekaBank Deutsche Girozentrale boosted its position in ANSYS by 4.6% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 522,613 shares of the software maker’s stock worth $167,985,000 after buying an additional 22,836 shares during the period. Institutional investors own 92.39% of the company’s stock.

About ANSYS

(Get Free Report)

ANSYS, Inc develops and markets engineering simulation software and services for engineers, designers, researchers, and students in the United States, Japan, Germany, China, Hong Kong, South Korea, rest of Europe, the Middle East, Africa, and internationally. It offers structural analysis product suite that provides simulation tools for product design and optimization; the Ansys Mechanical product, an element analysis software; LS-DYNA solver for multiphysics simulation; and power analysis and optimization software suite.

See Also

Receive News & Ratings for ANSYS Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ANSYS and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

ABMN Staff

Source link

August 28, 2024
TELUS (NYSE:TU) Raised to Hold at StockNews.com

[ad_1]

StockNews.com upgraded shares of TELUS (NYSE:TU – Free Report) (TSE:T) from a sell rating to a hold rating in a research note published on Tuesday.

Several other brokerages have also weighed in on TU. Scotiabank dropped their target price on TELUS from C$29.50 to C$28.00 in a research report on Tuesday, August 8th. CIBC dropped their target price on TELUS from C$31.00 to C$29.00 in a research report on Monday, July 17th. JPMorgan Chase & Co. lowered their price target on TELUS from C$33.00 to C$31.00 in a report on Thursday, July 20th. Bank of America lowered their price target on TELUS from C$33.00 to C$30.00 in a report on Friday, October 6th. Finally, Desjardins lowered their price target on TELUS from C$29.00 to C$27.50 in a report on Friday, July 14th.

Get Our Latest Stock Analysis on TELUS

TELUS Price Performance

Shares of NYSE TU opened at $17.45 on Tuesday. TELUS has a 1-year low of $15.47 and a 1-year high of $22.08. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.63 and a quick ratio of 0.57. The business’s fifty day moving average price is $16.73 and its two-hundred day moving average price is $18.22. The firm has a market capitalization of $25.37 billion, a PE ratio of 42.56, a P/E/G ratio of 3.23 and a beta of 0.73.

TELUS Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Monday, December 11th will be issued a dividend of $0.271 per share. This represents a $1.08 dividend on an annualized basis and a yield of 6.21%. The ex-dividend date of this dividend is Friday, December 8th. TELUS’s payout ratio is currently 263.42%.

Hedge Funds Weigh In On TELUS

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Bessemer Group Inc. boosted its position in TELUS by 227.5% during the 1st quarter. Bessemer Group Inc. now owns 1,598 shares of the Wireless communications provider’s stock worth $32,000 after acquiring an additional 1,110 shares during the period. Ridgewood Investments LLC acquired a new stake in TELUS during the 1st quarter worth about $32,000. Glass Jacobson Investment Advisors llc acquired a new stake in TELUS during the 2nd quarter worth about $70,000. Captrust Financial Advisors boosted its position in TELUS by 18.1% during the 2nd quarter. Captrust Financial Advisors now owns 4,669 shares of the Wireless communications provider’s stock worth $104,000 after acquiring an additional 717 shares during the period. Finally, Pacer Advisors Inc. boosted its position in TELUS by 29.1% during the 2nd quarter. Pacer Advisors Inc. now owns 4,681 shares of the Wireless communications provider’s stock worth $91,000 after acquiring an additional 1,054 shares during the period. Institutional investors and hedge funds own 49.48% of the company’s stock.

TELUS Company Profile

(Get Free Report)

TELUS Corporation, together with its subsidiaries, provides a range of telecommunications and information technology products and services in Canada. It operates through Technology Solutions and Digitally-Led Customer Experiences segments. The Technology Solutions segment offers a range of telecommunications products and services; network services; mobile technologies equipment; data services, such as internet protocol; television; hosting, managed information technology, and cloud-based services; software, data management, and data analytics-driven smart food-chain and consumer goods technologies; home and business security; healthcare software and technology solutions; and voice and other telecommunications services.

Read More

Receive News & Ratings for TELUS Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for TELUS and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

ABMN Staff

Source link

November 8, 2023
Companhia Brasileira De Distribuicao (NYSE:CBD) Now Covered by StockNews.com – Medical Marijuana Program Connection

[ad_1]

StockNews.com began coverage on shares of Companhia Brasileira De Distribuicao (NYSE:CBD – Free Report) in a research note published on Wednesday. The firm issued a hold rating on the stock.

Companhia Brasileira De Distribuicao Trading Up 5.1 %

CBD opened at $0.76 on Wednesday. The business has a fifty day moving average of $0.81 and a 200 day moving average of $2.70. Companhia Brasileira De Distribuicao has a 52-week low of $0.58 and a 52-week high of $4.76. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.49 and a current ratio of 1.32.

Hedge Funds Weigh In On Companhia Brasileira De Distribuicao

A number of large investors have recently bought and sold shares of CBD. Mirae Asset Global Investments Co. Ltd. bought a new stake in Companhia Brasileira De Distribuicao during the 1st quarter valued at $34,000. Millennium Management LLC bought a new stake in Companhia Brasileira De Distribuicao during the 4th quarter valued at $35,000. Eqis Capital Management Inc. bought a new stake in Companhia Brasileira De Distribuicao during the 2nd quarter valued at $47,000. Northern Trust Corp bought a new stake in Companhia Brasileira De Distribuicao during the 2nd quarter valued at $54,000. Finally, Citigroup Inc. raised its position in Companhia Brasileira De Distribuicao by 80.3% during the 1st quarter. Citigroup Inc. now owns 18,998 shares of the company’s stock valued at $56,000 after purchasing an additional 8,459 shares in the last quarter. Hedge…

Original Author Link click here to read complete story..

[ad_2]

MMP News Author

Source link

November 5, 2023
Insignia Systems (NASDAQ:ISIG) Research Coverage Started at StockNews.com

[ad_1]

Equities researchers at StockNews.com initiated coverage on shares of Insignia Systems (NASDAQ:ISIG – Get Free Report) in a research report issued on Monday. The brokerage set a “sell” rating on the business services provider’s stock.

Insignia Systems Stock Up 0.5 %

Insignia Systems stock opened at $7.61 on Monday. The stock has a market cap of $13.70 million, a PE ratio of 1.18 and a beta of 1.87. Insignia Systems has a 12-month low of $5.48 and a 12-month high of $9.84. The business’s 50-day moving average price is $7.65 and its two-hundred day moving average price is $7.99.

Insignia Systems (NASDAQ:ISIG – Get Free Report) last issued its quarterly earnings data on Tuesday, May 9th. The business services provider reported $0.91 earnings per share for the quarter. Insignia Systems had a net margin of 45.65% and a return on equity of 103.74%. The company had revenue of $12.83 million for the quarter.

Institutional Investors Weigh In On Insignia Systems

Institutional investors and hedge funds have recently modified their holdings of the company. Citigroup Inc. purchased a new position in shares of Insignia Systems during the first quarter worth approximately $33,000. Dimensional Fund Advisors LP purchased a new position in Insignia Systems in the 1st quarter worth $138,000. Finally, Millennium Management LLC purchased a new position in Insignia Systems in the 2nd quarter worth $133,000. 5.71% of the stock is owned by hedge funds and other institutional investors.

About Insignia Systems

(Get Free Report)

Insignia Systems, Inc provides in-store advertising solutions to consumer-packaged goods manufacturers, retailers, shopper marketing agencies, and brokerages in the United States. It offers in-store signage solutions, which provides point-of-purchase services, brand equity signs, tear pads, and display marketing solutions; display solutions, such as a range of fully customized temporary, semi-permanent, and permanent displays; merchandising solutions; and on-pack solutions, which include BoxTalk, coupons, recipes, and cross-promotions.

See Also

Receive News & Ratings for Insignia Systems Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Insignia Systems and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

ABMN Staff

Source link

July 19, 2023
Pearson (NYSE:PSO) Upgraded at StockNews.com

[ad_1]

StockNews.com upgraded shares of Pearson (NYSE:PSO – Get Rating) from a hold rating to a buy rating in a research note released on Friday morning.

Other analysts also recently issued research reports about the stock. Exane BNP Paribas downgraded shares of Pearson from an outperform rating to a neutral rating in a report on Thursday, December 1st. JPMorgan Chase & Co. increased their price objective on shares of Pearson from GBX 1,200 ($14.43) to GBX 1,230 ($14.79) in a report on Thursday. BNP Paribas downgraded shares of Pearson from an outperform rating to a neutral rating in a report on Thursday, December 1st. Barclays cut their price objective on shares of Pearson from GBX 945 ($11.36) to GBX 915 ($11.00) in a report on Monday, March 6th. Finally, Morgan Stanley increased their price target on shares of Pearson from GBX 900 ($10.82) to GBX 940 ($11.30) in a research note on Friday, December 16th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Hold and an average target price of $1,020.43.

Pearson Stock Performance

PSO opened at $10.17 on Friday. Pearson has a twelve month low of $8.84 and a twelve month high of $12.03. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.84 and a current ratio of 1.91. The company has a 50-day moving average price of $11.04 and a 200 day moving average price of $10.83.

Hedge Funds Weigh In On Pearson

A number of hedge funds have recently made changes to their positions in PSO. Signaturefd LLC raised its holdings in shares of Pearson by 10.0% in the 3rd quarter. Signaturefd LLC now owns 10,518 shares of the company’s stock valued at $100,000 after purchasing an additional 953 shares in the last quarter. Evergreen Capital Management LLC raised its holdings in shares of Pearson by 8.3% in the 3rd quarter. Evergreen Capital Management LLC now owns 14,693 shares of the company’s stock valued at $140,000 after purchasing an additional 1,132 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Pearson by 11.0% during the 1st quarter. JPMorgan Chase & Co. now owns 11,590 shares of the company’s stock worth $116,000 after acquiring an additional 1,153 shares in the last quarter. Captrust Financial Advisors raised its stake in Pearson by 88.3% during the 2nd quarter. Captrust Financial Advisors now owns 3,064 shares of the company’s stock worth $28,000 after acquiring an additional 1,437 shares in the last quarter. Finally, Schechter Investment Advisors LLC raised its stake in Pearson by 4.9% during the 3rd quarter. Schechter Investment Advisors LLC now owns 31,103 shares of the company’s stock worth $297,000 after acquiring an additional 1,451 shares in the last quarter. Hedge funds and other institutional investors own 2.83% of the company’s stock.

About Pearson

(Get Rating)

Pearson Plc engages in the business of education, business information, and consumer publishing markets. It operates through the following segments: Global Online Learning, Global Assessment, North American Courseware, and International. The Global Online Learning segment offers virtual schools and online program management.

Featured Stories

Receive News & Ratings for Pearson Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Pearson and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

ABMN Staff

Source link

March 13, 2023
Höegh LNG Partners (NYSE:HMLP) Now Covered by Analysts at StockNews.com

[ad_1]

StockNews.com started coverage on shares of Höegh LNG Partners (NYSE:HMLP – Get Rating) in a research report released on Tuesday. The brokerage issued a buy rating on the shipping company’s stock.

Höegh LNG Partners Price Performance

Shares of NYSE HMLP opened at $9.24 on Tuesday. Höegh LNG Partners has a 12-month low of $3.77 and a 12-month high of $9.25. The stock has a market cap of $308.37 million, a PE ratio of 6.00 and a beta of 1.39. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.79. The company has a 50-day moving average of $9.24 and a 200 day moving average of $9.23.

Institutional Trading of Höegh LNG Partners

Several large investors have recently bought and sold shares of the business. Prelude Capital Management LLC grew its stake in Höegh LNG Partners by 588.0% during the 2nd quarter. Prelude Capital Management LLC now owns 125,063 shares of the shipping company’s stock valued at $1,124,000 after acquiring an additional 106,885 shares in the last quarter. PenderFund Capital Management Ltd. purchased a new stake in shares of Höegh LNG Partners in the 2nd quarter valued at approximately $189,000. PEAK6 Investments LLC purchased a new stake in shares of Höegh LNG Partners in the 2nd quarter valued at approximately $146,000. JPMorgan Chase & Co. grew its stake in shares of Höegh LNG Partners by 13.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,053,546 shares of the shipping company’s stock valued at $9,471,000 after buying an additional 126,426 shares during the period. Finally, Keebeck Alpha LP purchased a new stake in shares of Höegh LNG Partners in the 2nd quarter valued at approximately $1,503,000. Hedge funds and other institutional investors own 17.69% of the company’s stock.

Höegh LNG Partners Company Profile

(Get Rating)

Höegh LNG Partners LP focuses on owning, operating, and acquiring floating storage and regasification units (FSRUs), liquefied natural gas (LNG) carriers, and other LNG infrastructure assets under long-term charters. As of March 31, 2022, it had a fleet of five FSRUs. Höegh LNG GP LLC is the general partner of the company.

See Also

Receive News & Ratings for Höegh LNG Partners Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Höegh LNG Partners and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

ABMN Staff

Source link

February 21, 2023
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX)

[ad_1]

StockNews.com started coverage on shares of IRIDEX (NASDAQ:IRIX – Get Rating) in a research note issued to investors on Monday. The firm issued a buy rating on the medical equipment provider’s stock.

IRIDEX Stock Performance

Shares of IRIDEX stock opened at $2.21 on Monday. The company has a market capitalization of $35.33 million, a PE ratio of -4.02 and a beta of 1.27. The company has a 50-day simple moving average of $2.14 and a two-hundred day simple moving average of $2.45. IRIDEX has a one year low of $1.96 and a one year high of $5.88.

IRIDEX (NASDAQ:IRIX – Get Rating) last posted its quarterly earnings data on Thursday, November 10th. The medical equipment provider reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.04. IRIDEX had a negative net margin of 15.50% and a negative return on equity of 43.06%. The firm had revenue of $14.64 million for the quarter, compared to the consensus estimate of $13.87 million. On average, equities analysts predict that IRIDEX will post -0.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On IRIDEX

Several hedge funds have recently bought and sold shares of the stock. Paragon Associates & Paragon Associates II Joint Venture boosted its position in IRIDEX by 42.1% in the 3rd quarter. Paragon Associates & Paragon Associates II Joint Venture now owns 799,385 shares of the medical equipment provider’s stock worth $1,927,000 after purchasing an additional 236,715 shares in the last quarter. Isthmus Partners LLC lifted its position in shares of IRIDEX by 26.0% during the 2nd quarter. Isthmus Partners LLC now owns 286,139 shares of the medical equipment provider’s stock valued at $735,000 after buying an additional 59,020 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of IRIDEX by 4.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 240,729 shares of the medical equipment provider’s stock valued at $1,115,000 after buying an additional 9,361 shares in the last quarter. Perkins Capital Management Inc. lifted its position in shares of IRIDEX by 15.9% during the 2nd quarter. Perkins Capital Management Inc. now owns 80,346 shares of the medical equipment provider’s stock valued at $206,000 after buying an additional 11,000 shares in the last quarter. Finally, State Street Corp lifted its position in shares of IRIDEX by 9.7% during the 1st quarter. State Street Corp now owns 44,718 shares of the medical equipment provider’s stock valued at $207,000 after buying an additional 3,956 shares in the last quarter. Hedge funds and other institutional investors own 28.63% of the company’s stock.

IRIDEX Company Profile

(Get Rating)

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.

Read More

Receive News & Ratings for IRIDEX Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for IRIDEX and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

ABMN Staff

Source link

January 17, 2023